DIVISLABDivi's Laboratories Ltd.

    Divi's Laboratories Ltd: results and news

    Every Divi's Laboratories Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Active pharmaceutical ingredients · Latest 7 Nov 2026

    An industrial chemical processing plant with steel pipework, pressure vessels and yellow railings on a blue frame

    DIVISLABDivi's Laboratories Ltd.

    Divi's Laboratories Q2 FY27 Results: Consolidated Net Profit ₹1,127 Crore on Total Income of ₹3,770 Crore

    Divi's Laboratories (NSE: DIVISLAB) reported consolidated total income of ₹3,770 crore and net profit of ₹1,127 crore for the quarter ended 30 Sep 2026, it said in a filing on 07 Nov 2026. Standalone total income was ₹3,735 crore and standalone net profit ₹1,140 crore for the same quarter.

    • Earnings
    • Active pharmaceutical ingredients

    Blacklitt Research3 min read